Bolaamphiphilic compounds, compositions and uses thereof
AssigneeLauren Sciences LLC
InventorsCharles LINDER, Eliahu HELDMAN, Sarina GRINBERG
Life of this patent
Estimating the term…
Abstract
Bolaamphiphilic compounds are provided according to formula I: HG2-L1-HG1 I where HG1, HG2 and L1 are as defined herein. Provided bolaamphilphilic compounds and the pharmaceutical compositions thereof are useful for delivering biologically active drugs into animal or human brain.
Claims73
A pharmaceutical composition or a formulation comprising a bolaamphiphile complex, a sub-micron sized vesicle, or nano-sized vesicle;
- wherein the bolaamphiphile complex or nano-sized vesicles comprises one or more bolaamphiphilic compounds and a biologically active compound, wherein the bolaamphiphilic compound is a compound according to formula I:
- HG2-L1-HG1 I
- or a pharmaceutically acceptable salt, solvate, hydrate, prodrug, stereoisomer, tautomer, isotopic variant, or N-oxide thereof, or a combination thereof;
- wherein:
- each HG1 and HG2 is independently a hydrophilic head group;
- and
- L1 is alkylene, alkenyl, heteroalkylene, or heteroalkenyl linker;
- unsubstituted or substituted with C1-C20 alkyl, hydroxyl, or oxo.
3-4. (canceled)
(canceled)
7-9. (canceled)
11-13. (canceled)
(canceled)
17-18. (canceled)
20-22. (canceled)
24-25. (canceled)
27-28. (canceled)
(canceled)
33-37. (canceled)
42-43. (canceled)
45-46. (canceled)
48-49. (canceled)
(canceled)
(canceled)
57-60. (canceled)
(canceled)
72-80. (canceled)
86-88. (canceled)
Dependencies are inferred from the claim text.